These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36310922)

  • 1. Anti-fibrillization effects of sulfonamide derivatives on
    Fortin JS; Shimanaka K; Saraswati AP; Liu M; Wang KW; Hagar HT; Maity S; Ganegamage SK; Ellsworth E; Counts SE; Borhan B; Dettmer U; Kuo MH
    J Mol Struct; 2022 Nov; 1267():. PubMed ID: 36310922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 4-aminoindole carboxamide derivatives to curtail alpha-synuclein and tau isoform 2N4R oligomer formation.
    Ramirez E; Min S; Ganegamage SK; Shimanaka K; Sosa MG; Dettmer U; Rochet JC; Fortin JS
    Results Chem; 2023 Jan; 5():. PubMed ID: 37346091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation.
    Ramirez E; Ganegamage SK; Min S; Patel H; Ogunware A; Plascencia-Villa G; Alnakhala H; Shimanaka K; Tripathi A; Wang KW; Zhu X; Rochet JC; Kuo MH; Counts SE; Perry G; Dettmer U; Lasagna-Reeves CA; Fortin JS
    ACS Chem Neurosci; 2023 Nov; 14(21):3913-3927. PubMed ID: 37818657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils.
    Elbatrawy AA; Ademoye TA; Alnakhala H; Tripathi A; Zami A; Ostafe R; Dettmer U; Fortin JS
    Bioorg Med Chem; 2024 Feb; 100():117613. PubMed ID: 38330847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α-Synuclein Oligomer Formation
    Ganegamage SK; Ramirez E; Alnakhala H; Tripathi A; Nguyen CCD; Zami A; Ostafe R; Tian S; Dettmer U; Fortin JS
    ACS Omega; 2024 Jan; 9(1):1216-1229. PubMed ID: 38222653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Nitro-1,2-benzothiazol-3-amine and
    Ramirez E; Ganegamage SK; Elbatrawy AA; Alnakhala H; Shimanaka K; Tripathi A; Min S; Rochet JC; Dettmer U; Fortin JS
    ACS Omega; 2023 Jun; 8(22):20102-20115. PubMed ID: 37305264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration.
    Gabr MT; Peccati F
    ACS Chem Neurosci; 2020 Jul; 11(14):2051-2057. PubMed ID: 32579329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.
    Waxman EA; Giasson BI
    J Neurosci; 2011 May; 31(21):7604-18. PubMed ID: 21613474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.
    Duka T; Sidhu A
    Neurotox Res; 2006 Aug; 10(1):1-10. PubMed ID: 17000465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology.
    Bassil F; Brown HJ; Pattabhiraman S; Iwasyk JE; Maghames CM; Meymand ES; Cox TO; Riddle DM; Zhang B; Trojanowski JQ; Lee VM
    Neuron; 2020 Jan; 105(2):260-275.e6. PubMed ID: 31759806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death.
    Liu M; Sui D; Dexheimer T; Hovde S; Deng X; Wang KW; Lin HL; Chien HT; Kweon HK; Kuo NS; Ayoub CA; Jimenez-Harrison D; Andrews PC; Kwok R; Bochar DA; Kuret J; Fortin J; Tsay YG; Kuo MH
    Mol Neurobiol; 2020 Nov; 57(11):4704-4719. PubMed ID: 32780352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation.
    Mancini RS; Wang Y; Weaver DF
    Front Neurosci; 2018; 12():735. PubMed ID: 30369868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease.
    Shim KH; Kang MJ; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2022 Dec; 14(1):201. PubMed ID: 36587215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
    Liu M; Dexheimer T; Sui D; Hovde S; Deng X; Kwok R; Bochar DA; Kuo MH
    Sci Rep; 2020 Oct; 10(1):16551. PubMed ID: 33024171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary levels of disease-related biomarkers in the early stages of Parkinson's and Alzheimer's disease:
    Sabaei M; Rahimian S; Haj Mohamad Ebrahim Ketabforoush A; Rasoolijazi H; Zamani B; Hajiakhoundi F; Soleimani M; Shahidi G; Faramarzi M
    IBRO Neurosci Rep; 2023 Jun; 14():285-292. PubMed ID: 36942319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U; Kayed R
    Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.
    Toledo JB; Korff A; Shaw LM; Trojanowski JQ; Zhang J
    Acta Neuropathol; 2013 Nov; 126(5):683-97. PubMed ID: 23812319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: A comparative study.
    Jangholi A; Ashrafi-Kooshk MR; Arab SS; Riazi G; Mokhtari F; Poorebrahim M; Mahdiuni H; Kurganov BI; Moosavi-Movahedi AA; Khodarahmi R
    Arch Biochem Biophys; 2016 Nov; 609():1-19. PubMed ID: 27638048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.